To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Bio-Reference Laboratories Announces Agreement to Acquire GeneDx
Bio-Reference Laboratories, Inc. has announced it has executed a Purchase Agreement for the acquisition of GeneDx and released its third quarter, fiscal year 2006 earnings for the three months ending July 31.
Marc Grodman, M.D., CEO of BRLI, stated, "We executed an Agreement today for the acquisition of GeneDx."
"The Closing, expected to be completed within the next two to three weeks, is subject to the obtaining of certain consents."
"This acquisition, when consummated, will represent a major new initiative for our company."
"We believe GeneDx is the country's leading laboratory for the diagnosis of rare and complex genetic disorders; it is a pure genetics laboratory that is actually run by geneticists."
"DNA sequencing is the current gold standard of genetic testing and GeneDx with its expansive and, what we believe to be, unrivaled roster of testing holds a preeminent position in this diagnostic testing area."
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
